New Study Finds Brain Inflammation to Be Treatable

A new study conducted by DR. Orser and Dr. Wang in Toronto has suggested that using drugs to target the hippocampus that memory loss may be reversible. This was a joint study conducted between the University of Toronto and Sunnybrook Hospital. This type of inflammation is linked to a number of disorders and can be caused by stroke, Alzheimer’s, injury, or infection.

The study found that a protein IL-1B works to block memory receptors which caused loss of memory in mice test subjects. This protein stimulates greatly release of the gamma aminobutyric acid A receptor, alpha 5 protein. However once the mice were treated with a drug that worked to block IL-1B the mice recovered their memory. These promising results could help develop a cure for memory loss in the near future.

The study which was published in the journal Cell Reports provided an explanation for loss of memory and has suggested a process in which it could be reversed. The researchers are hopeful that a clinic trial into treating memory loss caused by surgery will be conducted soon. If successful this study could result for new treatments for a number of different conditions including strokes, and Alzheimer’s. This research into memory loss and potential treatments is being funded by the Canadian Institutes of Health Research.

Source: The Globe And Mail



Angela is the editor of Activebeat and is an avid health enthusiast. She’s our source for great fitness and exercise tips and is dedicated to bringing you the breaking news stories each day. From recalls and outbreaks to FDA announcements and alerts, she’ll keep you up-to-date with the most important health news every day.